BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28265231)

  • 41. Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney.
    Olweny EO; Kapur P; Tan YK; Park SK; Adibi M; Cadeddu JA
    Urology; 2013 Mar; 81(3):679-84. PubMed ID: 23290141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Real-time ultrasound imaging of irreversible electroporation in a porcine liver model adequately characterizes the zone of cellular necrosis.
    Schmidt CR; Shires P; Mootoo M
    HPB (Oxford); 2012 Feb; 14(2):98-102. PubMed ID: 22221570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Percutaneous ultrasound-guided irreversible electroporation: A goat liver study.
    Liu Y; Xiong Z; Zhou W; Hua Y; Li C; Yao C
    Oncol Lett; 2012 Sep; 4(3):450-454. PubMed ID: 24527063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pilot Study of the Safety and Efficacy of Gallbladder Cryoablation in a Porcine Model: Midterm Results.
    McGregor HCJ; Surman A; Fernandez A; Saeed M; Wilson M; Hetts S; Conrad M
    J Vasc Interv Radiol; 2018 Mar; 29(3):340-344. PubMed ID: 29395896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel irreversible electroporation ablation (Nano-knife) versus radiofrequency ablation for the treatment of solid liver tumors: a comparative, randomized, multicenter clinical study.
    Zhang X; Zhang X; Ding X; Wang Z; Fan Y; Chen G; Hu X; Zheng J; Xue Z; He X; Zhang X; Wei Y; Zhang Z; Li J; Li J; Yang J; Xue X; Ma L; Xiao Y
    Front Oncol; 2022; 12():945123. PubMed ID: 36249062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Effects of Irreversible Electroporation on the Colon in a Porcine Model.
    Luo X; Liang X; Li J; Shi J; Zhang W; Chai W; Wu J; Guo S; Fang G; Zhou X; Zhang J; Xu K; Zeng J; Niu L
    PLoS One; 2016; 11(12):e0167275. PubMed ID: 27907057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Irreversible electroporation versus radiofrequency ablation for malignant hepatic tumor: A prospective single-center double-arm trial.
    Liu B; Fu D; Fan Y; Wang Z; Lang X
    J Interv Med; 2022 May; 5(2):89-94. PubMed ID: 35936662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination therapy comprising irreversible electroporation and hydroxycamptothecin loaded electrospun membranes to treat rabbit VX2 subcutaneous cancer.
    Wang L; Chang J; Qu Y; Qiu R
    Biomed Microdevices; 2018 Oct; 20(4):88. PubMed ID: 30310996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative Effects of Irreversible Electroporation, Radiofrequency Ablation, and Partial Nephrectomy on Renal Function Preservation in a Porcine Solitary Kidney Model.
    Morgan MS; Ozayar A; Lucas E; Friedlander JI; Shakir NA; Cadeddu JA
    Urology; 2016 Aug; 94():281-7. PubMed ID: 27155310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pain After Percutaneous Irreversible Electroporation of Renal Tumors Is Not Dependent on Tumor Location.
    Sorokin I; Lay AH; Reddy NK; Canvasser NE; Chamarthy M; Cadeddu JA
    J Endourol; 2017 Aug; 31(8):751-755. PubMed ID: 28586250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.
    Scheffer HJ; Nielsen K; de Jong MC; van Tilborg AA; Vieveen JM; Bouwman AR; Meijer S; van Kuijk C; van den Tol PM; Meijerink MR
    J Vasc Interv Radiol; 2014 Jul; 25(7):997-1011; quiz 1011. PubMed ID: 24656178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC).
    Bhutiani N; Philips P; Scoggins CR; McMasters KM; Potts MH; Martin RC
    HPB (Oxford); 2016 Jul; 18(7):593-9. PubMed ID: 27346140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Upper-Urinary-Tract Effects After Irreversible Electroporation (IRE) of Human Localised Renal-Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Ablate-and-Resect Study.
    Wendler JJ; Pech M; Köllermann J; Friebe B; Siedentopf S; Blaschke S; Schindele D; Porsch M; Baumunk D; Jürgens J; Fischbach F; Ricke J; Schostak M; Böhm M; Liehr UB
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):466-476. PubMed ID: 28929209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation.
    Lee EW; Chen C; Prieto VE; Dry SM; Loh CT; Kee ST
    Radiology; 2010 May; 255(2):426-33. PubMed ID: 20413755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
    Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
    BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An
    Zhang B; Liu F; Fang Z; Ding L; Moser MAJ; Zhang W
    Int J Hyperthermia; 2021; 38(1):593-603. PubMed ID: 33853496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of targeted argon-helium cryoablation on the portal region in canine livers].
    Yu HB; Ge CL; Huang ZH; Wang H; Liu ZY; Zhang JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):538-40. PubMed ID: 19304548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severe complications with irreversible electroporation of the pancreas in the presence of a metallic stent: a warning of a procedure that never should be performed.
    Månsson C; Nilsson A; Karlson BM
    Acta Radiol Short Rep; 2014 Dec; 3(11):2047981614556409. PubMed ID: 25535573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of irreversible electroporation on femoral nerves in a rabbit model.
    Kwon JH; Kim MD; Kim SH; Lee EW; Kahlid SA
    Minim Invasive Ther Allied Technol; 2022 Feb; 31(2):306-312. PubMed ID: 32744129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
    Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
    Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.